Mexquisite Recall (April 2025): Salsa Cilantro

On April 25, 2025, Mexquisite, Inc. began a Class II recall. Reason: Potential foreign object contamination.

In plain words

What

Salsa Cilantro 8.5lb plastic jugs packaged 4 jugs to case. MSC12114

Why

Potential foreign object contamination

Where

California, Texas.

Distribution as reported to FDA: Texas and California

How serious

Class II: the FDA uses this class for a situation where eating the product may cause temporary or medically reversible health problems, or where the chance of serious health problems is remote.

Status: Terminated. FDA has closed the recall. Closed July 1, 2026.

What to do

Compare the product name, size, UPC and lot or date codes below with what you have. The FDA Enforcement Report is the official record of this recall; for instructions on returns or refunds, follow the notice or contact Mexquisite, Inc..

Official notice ↗

The recalled product1

FDA recall H-0001-2025 · Class II · Terminated

Salsa Cilantro 8.5lb plastic jugs packaged 4 jugs to case. MSC12114

Codes:
MSC12114
Quantity:
339 cases

Recall record

Agency
U.S. Food and Drug Administration (FDA)
Recalling firm
Mexquisite, Inc., San Antonio, TX
Recall started
April 25, 2025
FDA Enforcement Report
June 11, 2025
Initiated
Voluntary: Firm initiated
Recall number
H-0001-2025
FDA event ID
96899

Latest food recalls

JXK Enterprises, Inc is voluntarily recalling Boner Bears Chocolate, Lot #BB21125, after being notified that FDA laboratory analysis confirmed the presence of sildenafil, an active ingredient in the FDA-approved prescription drug Viagra, which is not declared on the product label.

Nationwide · Ongoing

All food recalls

Recall details come from the U.S. Food and Drug Administration's Enforcement Reports (through openFDA) and from USDA's Food Safety and Inspection Service recalls and public health alerts, checked daily. MealSlash shows what the agency published and links every recall to its official notice; the notice is the authority. openFDA's note: do not rely on openFDA to make decisions regarding medical care.